A patient presented with multiple nodulocystic lesions on the face. The drug of choice is :
**Core Concept**
The question is testing the knowledge of appropriate drug choice for the management of nodulocystic acne, a severe form of acne vulgaris characterized by enlarged, inflamed nodules and pustules. Acne vulgaris is a chronic inflammatory condition affecting the sebaceous glands and hair follicles, primarily in the face, chest, and back. Nodulocystic acne is typically seen in adult females, and its management requires potent topical and systemic medications.
**Why the Correct Answer is Right**
The correct answer is based on understanding the pathophysiology of nodulocystic acne and the mechanism of action of the chosen drug. The correct answer (C) is isotretinoin, a retinoid that acts as a vitamin A derivative. Isotretinoin works via multiple mechanisms:
1. **Suppresses sebum production:** Isotretinoin inhibits the enzyme 17Ξ±-hydroxylase/17,20-lyase (CYP17) in the adrenal and gonadal glands, thus reducing the synthesis of cortisol, aldosterone, and testosterone, which are related to increased sebum production.
2. **Inhibits keratinocyte proliferation and differentiation:** Isotretinoin affects the differentiation of keratinocytes, leading to decreased inflammation and scarring.
3. **Modifies the immune response:** Isotretinoin reduces the inflammatory response in the skin, which helps to explain its anti-inflammatory and antimicrobial effects.
**Why Each Wrong Option is Incorrect**
A) Erythromycin is an antibiotic used to treat mild to moderate acne, targeting the bacterial component of acne. It does not address the hormonal component or inflammation present in nodulocystic acne.
B) Topical retinoids like tretinoin work primarily on the skin surface, addressing the keratinization and inflammation but do not address the hormonal component.
D) Doxycycline is an antibiotic used to treat mild to moderate acne, targeting the bacterial component of acne. It does not address the hormonal component or inflammation present in nodulocystic acne.
**Clinical Pearls**
1. **Acne treatment should be tailored to the severity of acne:** For more severe forms like nodulocystic acne, a combination of systemic agents targeting both bacterial and hormonal components is necessary.
2. **Monitoring of patients on isotretinoin:** Regular monitoring for side effects (e.g., lipid profile, liver function tests, and psychological evaluation) is crucial due to the systemic effects of isotretinoin.
**Why the Correct Answer is Right**
Isotretinoin (a synthetic derivative of vitamin A) is an effective systemic therapy for severe acne, including nodulocystic acne, due to its systemic effects on sebaceous gland hormones and keratinization, as well as its anti-inflammatory and antimicrobial properties.